Nelarabine and sensory loss Patient Reports February 10, 2010

Nelarabine Side Effects Report #5376904-2
Nelarabine side effect was reported by a Physician from UNITED STATES on June 28, 2007. Male patient, 19 years of age, weighting 154.3 lb, was diagnosed with t-cell type acute leukaemia and was treated with Nelarabine. After drug was administered, patient experienced the following side effects: asthenia, hypoaesthesia, hypotonia, neuropathy, sensory loss. Nelarabine dosage: 1090 MG QD IV. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, CYTARABINE. Patient was hospitalized and became disabled. Patient recovered.